These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36993061)

  • 1. The hepatitis virus infection and renal replacement therapies: What is the relation?
    Pustake M; Giri P; Ganiyani MA; Purwar S
    J Family Med Prim Care; 2022 Nov; 11(11):7497-7498. PubMed ID: 36993061
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence and significance of hepatitis GB virus-c/hepatitis G virus viremia in a large cohort of patients with chronic hepatitis B infection, with chronic hepatitis C infection, and on renal replacement therapy in Hong Kong.
    Yuen MF; Chan TM; Yip TP; Yuen JC; Ho SK; Lai CL
    Dig Dis Sci; 2002 Feb; 47(2):432-7. PubMed ID: 11855563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.
    Fabrizi F; Lampertico P; Lunghi G; Mangano S; Aucella F; Martin P
    Aliment Pharmacol Ther; 2005 Mar; 21(6):623-32. PubMed ID: 15771749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to core antigen of hepatitis B virus in patients on renal replacement therapy: association with demographic, clinical and laboratory data.
    Grzegorzewska AE; Kurzawska-Firlej D; Ratajewski W; Frankiewicz D; Niepolski L; Kaczmarek A
    Nephron Clin Pract; 2010; 114(3):c194-203. PubMed ID: 19955825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies.
    Puchades Renau L; Berenguer M
    Hemodial Int; 2018 Apr; 22 Suppl 1():S8-S21. PubMed ID: 29694724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral treatment and prognosis in patients undergoing maintenance hemodialysis due to hepatitis C virus.
    Zhang W; Yuan Q; Ning J; Li X; Wu A; Xiao X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1332-1337. PubMed ID: 35232901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus genotypes in patients on renal replacement therapy.
    Chan TM; Lau JY; Wu PC; Lai CL; Lok AS; Cheng IK
    Nephrol Dial Transplant; 1998 Mar; 13(3):731-4. PubMed ID: 9550655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cholestatic hepatitis a virus infection presenting with hemolytic anemia and renal failure: a case report.
    Lapp RT; Rochling F
    Case Reports Hepatol; 2013; 2013():438375. PubMed ID: 25431704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of Hepatotropic Viruses Leading To Deranged Liver Function Tests in Renal Transplant Recipients.
    Asif M; Hanif FM; Luck NH; Tasneem AA
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):202-206. PubMed ID: 30777555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience.
    Sabry A
    Exp Clin Transplant; 2010 Jun; 8(2):91-7. PubMed ID: 20565364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of previous hepatitis A virus infection in renal transplant patients with hepatitis C: evidence of persistent anti-hepatitis A virus immune response.
    Mariya FA; de Mello Perez R; Silva AE; Pestana JO; Ferraz ML
    Transplant Proc; 2004 Jun; 36(5):1500-1. PubMed ID: 15251370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C.
    Kawagishi N; Suda G; Onozawa M; Kimura M; Maehara O; Ohara M; Izumi T; Umemura M; Ito J; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N
    J Viral Hepat; 2017 Dec; 24(12):1098-1106. PubMed ID: 28632923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta-analysis.
    De A; Roy A; Verma N; Mishra S; Premkumar M; Taneja S; Singh V; Duseja A
    Nephrology (Carlton); 2022 Jan; 27(1):82-89. PubMed ID: 34453374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis G virus infection in hemodialyzed children and adults following kidney transplantation].
    Szabó A; Heemann U; Müller V; Reusz G; Sallay P; Viazov S; Tulassay T
    Orv Hetil; 1999 Jul; 140(29):1619-23. PubMed ID: 10443139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma and hepatitis C virus infection: is there any cause-outcome relationship?
    Wiwanitkit V
    J Cancer Res Ther; 2011; 7(2):226-7. PubMed ID: 21768723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis delta virus among hemodialysis and renal transplant patients.
    Pierre AMMA; Feldner ACCA; Carvalho Filho RJ; Lopes EPA; Gouvea MSG; Pinho JRR; Carvente CT; Emori CT; Silva GAD; Ferraz MLCG
    Int J Artif Organs; 2018 Mar; 41(3):171-174. PubMed ID: 29546807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.